Healthcare -
Biotechnology - NASDAQ - US
$ 1.51
0.667 %
$ 3.38 M
Market Cap
-0.09
P/E
Price Target
Average
32.45%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
34.50%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Vincerx Pharma, Inc.
Wall Street analysts predict an average 1-year price target for VINC of $2 , with forecasts ranging from
a
low of
$2 to a high of $2 .
VINC Lowest Price Target
Wall Street Target
2 USD
32.45%
VINC Average Price Target
Wall Street Target
2 USD
32.45%
VINC Highest Price Target
Wall Street Target
2 USD
32.45%
REVENUE FORECAST
Revenue Forecast Chart VINC
EBIT FORECAST
EBIT Forecast Chart VINC
NET INCOME FORECAST
Net Income Chart VINC